Form CORRESP - Correspondence:
SEC Accession No. 0001628280-24-040360
Filing Date
2024-09-13
Accepted
2024-09-13 16:40:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9216
2 spyrelogoa.jpg GRAPHIC 57813
  Complete submission text file 0001628280-24-040360.txt   89918
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)